These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6482577)
61. Reaction to D-penicillamine in rheumatoid arthritis. Day AT; Golding JR Br Med J; 1973 Sep; 3(5880):593. PubMed ID: 4726943 [No Abstract] [Full Text] [Related]
62. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine]. Carter H; Job-Deslandre C; Delrieu F; Menkes CJ Therapie; 1984; 39(6):689-95. PubMed ID: 6531741 [No Abstract] [Full Text] [Related]
63. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy. Pickup ME; Dixon JS; Lowe JR; Wright V J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471 [TBL] [Abstract][Full Text] [Related]
64. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis. Yu TF; Roboz J; Johnson S; Kaung C J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720 [TBL] [Abstract][Full Text] [Related]
65. The technique of penicillamine administration in rheumatoid arthritis. Jaffe IA Arthritis Rheum; 1975; 18(5):513-4. PubMed ID: 1191352 [No Abstract] [Full Text] [Related]
71. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)]. Hoshi K; Mizushima Y Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901 [No Abstract] [Full Text] [Related]
72. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707 [TBL] [Abstract][Full Text] [Related]
73. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?]. Schlumpf U; Bussmann HU; Jerusalem F Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670 [TBL] [Abstract][Full Text] [Related]
74. Resumption of treatment with penicillamine after proteinuria. Hill H; Hill A; Davison AM Ann Rheum Dis; 1979 Jun; 38(3):229-31. PubMed ID: 485579 [TBL] [Abstract][Full Text] [Related]
75. [A case of malignant rheumatoid arthritis associated with myasthenia gravis by D-penicillamine treatment (author's transl)]. Suzuki H; Imai H; Shiokawa Y Ryumachi; 1980 Jun; 20(3):163-70. PubMed ID: 7414431 [No Abstract] [Full Text] [Related]
76. [Myasthenic syndrome--complication of D-penicillamine therapy]. Tellkamp F; Kunath B Z Arztl Fortbild (Jena); 1984; 78(11):439-42. PubMed ID: 6475118 [No Abstract] [Full Text] [Related]
77. Towards safer penicillamine prescribing. Macleod M J R Nav Med Serv; 1978; 64(1):15-9. PubMed ID: 650619 [No Abstract] [Full Text] [Related]
78. [Febrile reaction to D-penicillamine]. Seror P; Blotman F; Simon L Sem Hop; 1984 Mar; 60(11):784-5. PubMed ID: 6324360 [TBL] [Abstract][Full Text] [Related]
79. D-penicillamine withdrawal in rheumatoid arthritis. Ahern MJ; Hall ND; Case K; Maddison PJ Ann Rheum Dis; 1984 Apr; 43(2):213-7. PubMed ID: 6370151 [TBL] [Abstract][Full Text] [Related]
80. [Our experience in the treatment of rheumatoid arthritis with D-penicillamine]. Wysocka K; Kiczak J; Hawrylak E Wiad Lek; 1980 Apr; 33(8):607-10. PubMed ID: 7405223 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]